InvestorsHub Logo
Followers 7
Posts 644
Boards Moderated 0
Alias Born 09/24/2010

Re: Biotech Pharmer post# 3130

Thursday, 03/09/2017 1:02:03 PM

Thursday, March 09, 2017 1:02:03 PM

Post# of 3662
How $MNTR CEO Billingsley "earned" his "modest" salary.

2000 Loss of $200,684
2001 Loss of $292,588
2002 Loss of $281,587
2003 Loss of $180,511

In 2003, the SEC issued a "cease and desist" order against Chester.
(Google Chester Billingsley SEC)

2004 Loss of $117,645
2005 Profit $58,605
2006 Profit $36,449
2007 Loss of $93,033

A 1 for 1000 shares reverse split in 2007.

2008 Profit $36,500
2009 Loss of $124,521
2010 Two annual statements put out:
2010 Either a loss of $143,573
2010 or a loss of $556,689

2011 Profit $486,338
2012 Loss of $230,047
2013 Loss of $258,784
2014 Loss of $472,922
2015 Loss of $799,800
2016 Loss of $657,751 (through the Third Quarter)

Information taken from MNTR annual reports on the OTC website.

MODEST?

If salary were based on performance, could his salary be considered EXTRAVAGANT?

Billingsley Business Brilliance

Do due diligence
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNTR News